HK1141238A1 - Stable formulations of thiadiazole derivative - Google Patents

Stable formulations of thiadiazole derivative

Info

Publication number
HK1141238A1
HK1141238A1 HK10107726.4A HK10107726A HK1141238A1 HK 1141238 A1 HK1141238 A1 HK 1141238A1 HK 10107726 A HK10107726 A HK 10107726A HK 1141238 A1 HK1141238 A1 HK 1141238A1
Authority
HK
Hong Kong
Prior art keywords
stable formulations
thiadiazole derivative
thiadiazole
derivative
formulations
Prior art date
Application number
HK10107726.4A
Other languages
English (en)
Inventor
Hiroko Kusano
Dinesh Shyamdeo Mishra
Yoshikazu Tashiro
Yosuke Watanabe
Hong Zhuang
Original Assignee
Lilly Co Eli
Kyowa Hakko Kirin Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39735000&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1141238(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli, Kyowa Hakko Kirin Co Ltd filed Critical Lilly Co Eli
Publication of HK1141238A1 publication Critical patent/HK1141238A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK10107726.4A 2007-07-12 2010-08-13 Stable formulations of thiadiazole derivative HK1141238A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94926807P 2007-07-12 2007-07-12
PCT/US2008/069301 WO2009009470A1 (en) 2007-07-12 2008-07-07 Stable formulations of thiadiazole derivatiive

Publications (1)

Publication Number Publication Date
HK1141238A1 true HK1141238A1 (en) 2010-11-05

Family

ID=39735000

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10107726.4A HK1141238A1 (en) 2007-07-12 2010-08-13 Stable formulations of thiadiazole derivative

Country Status (28)

Country Link
US (1) US8222284B2 (es)
EP (1) EP2178508B1 (es)
JP (1) JP4875205B2 (es)
KR (1) KR101188036B1 (es)
CN (1) CN101730525A (es)
AR (1) AR067472A1 (es)
AU (1) AU2008275258A1 (es)
BR (1) BRPI0814039A2 (es)
CA (1) CA2694277C (es)
CL (1) CL2008001996A1 (es)
CO (1) CO6270304A2 (es)
CR (1) CR11210A (es)
DO (1) DOP2010000004A (es)
EA (1) EA016861B1 (es)
EC (1) ECSP109864A (es)
ES (1) ES2401477T3 (es)
GT (1) GT201000003A (es)
HK (1) HK1141238A1 (es)
IL (1) IL202382A0 (es)
MA (1) MA31880B1 (es)
MX (1) MX2010000468A (es)
NZ (1) NZ581791A (es)
PE (1) PE20090438A1 (es)
SV (1) SV2010003449A (es)
TN (1) TN2010000015A1 (es)
TW (1) TW200918050A (es)
UA (1) UA97672C2 (es)
WO (1) WO2009009470A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2447536B1 (en) 2009-06-26 2017-12-27 Mitsubishi Electric Corporation Refrigerant compressor

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7425636B2 (en) 2001-12-11 2008-09-16 Kyowa Hakko Kogyo Co., Ltd. Thiadiazoline derivative
WO2004092147A1 (ja) 2003-04-18 2004-10-28 Kyowa Hakko Kogyo Co., Ltd. Ｍ期キネシン阻害剤
EP1870404A4 (en) * 2005-03-22 2010-07-14 Kyowa Hakko Kirin Co Ltd MEANS FOR THE TREATMENT OF A HEMATOPOIETIC TUMOR
JP2008150291A (ja) * 2005-03-22 2008-07-03 Kyowa Hakko Kogyo Co Ltd 乾癬治療剤
JP5060285B2 (ja) 2005-03-22 2012-10-31 協和発酵キリン株式会社 固形腫瘍治療剤
JP2008137893A (ja) * 2005-03-22 2008-06-19 Kyowa Hakko Kogyo Co Ltd 関節炎治療剤
JP2006265107A (ja) * 2005-03-22 2006-10-05 Kyowa Hakko Kogyo Co Ltd 緑内障治療剤
EP1908755A4 (en) * 2005-06-24 2009-06-24 Kyowa Hakko Kirin Co Ltd THERAPEUTIC AGENT AGAINST RESTENOSIS

Also Published As

Publication number Publication date
UA97672C2 (ru) 2012-03-12
IL202382A0 (en) 2010-06-30
CO6270304A2 (es) 2011-04-20
CN101730525A (zh) 2010-06-09
CR11210A (es) 2010-06-23
US20110009458A1 (en) 2011-01-13
TW200918050A (en) 2009-05-01
PE20090438A1 (es) 2009-04-18
KR20100029827A (ko) 2010-03-17
JP4875205B2 (ja) 2012-02-15
ECSP109864A (es) 2010-03-31
EA201070136A1 (ru) 2010-06-30
GT201000003A (es) 2012-03-13
AR067472A1 (es) 2009-10-14
KR101188036B1 (ko) 2012-10-05
US8222284B2 (en) 2012-07-17
ES2401477T3 (es) 2013-04-19
EP2178508B1 (en) 2013-02-06
CA2694277A1 (en) 2009-01-15
BRPI0814039A2 (pt) 2017-10-03
DOP2010000004A (es) 2010-03-15
TN2010000015A1 (en) 2011-09-26
CA2694277C (en) 2013-04-09
NZ581791A (en) 2012-03-30
EP2178508A1 (en) 2010-04-28
CL2008001996A1 (es) 2009-05-22
JP2010533190A (ja) 2010-10-21
MX2010000468A (es) 2010-04-09
AU2008275258A1 (en) 2009-01-15
MA31880B1 (fr) 2010-12-01
SV2010003449A (es) 2010-08-10
EA016861B1 (ru) 2012-08-30
WO2009009470A1 (en) 2009-01-15

Similar Documents

Publication Publication Date Title
IL205130A0 (en) Solid formulations of crystalline compounds
HK1143731A1 (zh) 利培酮類化合物的緩釋製劑
ZA201000437B (en) Pharmaceutical compositions of rifaximin
SI2011486T1 (sl) Farmacevtski sestavki rifaksimina
ZA200905134B (en) Compositions of stable tiacumicins
IL206576A0 (en) Monosebacate of pyrazole derivative
SI2260029T1 (sl) Priprava morfolinskih derivatov
PL2442648T3 (pl) Preparaty neonikotynoidów niezawierające nmp
PL2173345T3 (pl) Doustna formulacja metadoksyny
EP2001400A4 (en) ORAL FORMULATIONS OF GLYCYL-2-METHYLPROLYL-GLUTAMATE
GB0624963D0 (en) Derivatives of 188-Glycyrrhetinic Acid
IL213918A0 (en) Galenic formulations of organic compounds
GB0713707D0 (en) Stable compositions
HK1137187A1 (en) Use of tocopherol
HK1142806A1 (en) Stable solid preparation of egualen sodium
ZA201202168B (en) Formulations comprising triptan compounds
HK1141238A1 (en) Stable formulations of thiadiazole derivative
IL195092A0 (en) Crystalline form of (s)-1-phenylethylammonium (r)-diphenyl-methanesulphinyl-acetate
GB0705179D0 (en) Formulations
HK1167317A1 (en) Improved pharmacokinetics of s-adenosylmethionine formulations s-
ZA200806439B (en) Stable dosage formulations of imidazolylalkyl-pyridines
PL383550A1 (pl) Nowe pochodne benzeno- i pirydopirydazynonów
IL206473A0 (en) Stable elsamitrucin salt formulations
GB0821710D0 (en) Derivatives of dihydroindolone
GB0611327D0 (en) Improvements to the stabilisation of active materials

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20160707